Literature DB >> 750606

Vitamin D metabolites and bone mineralization in man.

P Bordier, H Rasmussen, P Marie, L Miravet, J Gueris, A Ryckwaert.   

Abstract

A comparison was made of the biochemical and osseous effects of 25-hydroxyvitamin D3 [25(OH)D3], 1 alpha-25-hydroxyvitamin D3 [1 alpha, 25(OH)2D3], and 24,25-dihydroxyvitamin D3 [24,25(OH)2D3] in adult vitamin D-deficient man. Administration of 50 micrograms/d of 25(OH)D3 for 8 weeks led to a return of the mineralization front to normal associated with a return of TmPO4/GFR to normal, an increase in serum phosphate and calcium concentrations, a fall in serum IPTH, and a rise in serum alkaline phosphatase activity. Giving 2.5 micrograms/d of 1 alpha,25(OH)2D3 did not produce these effects. Administration of 1 alpha, 25 (OH)2D3 caused an increase in intestinal calcium absorption, and a rise in serum calcium associated with a fall in serum immunoreactive parathormone (IPTH) concentrations but no sustained rise in either alkaline phosphatase, serum phosphate concentration, nor in TmPO4/GFR. Its administration caused an increase in the extent of the osteoclastic bone resorption surface but the extent of the mineralization front remained subnormal. Administration of 20 micrograms/d of 24,25(OH)2D3 caused a fall in urinary calcium excretion and in serum IPTH, and a rise in serum alkaline phosphatase, but no change in TmPO4/GFR or serum phosphate, and only a slight increase in the extent of the mineralization front. Combined treatment with 1 alpha, 25(OH)2D3 and 24,25(OH)2D3 led to a return of the mineralization front of normal even though both TmPO4/GFR and serum phosphate concentration remained low. It is concluded that 1alpha,25(OH)2D3 is not the sole biologically active metabolite of vitamin D in man. It is apparent that either 25(OH)D3 or some as yet unidentified metabolite of 25(OH)D3 stimulates the renal tubular reabsorption of calcium and phosphate, and that the subsequent rise in serum phosphate concentrations along with the direct actions of 1 alpha-25(OH)2D3, 24,25(OH)2D3, and possibly 25(OH)D3 on bone cells all participate in the restoration of normal bone formation and bone mineralization in vitamin D-deficient man.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 750606     DOI: 10.1210/jcem-46-2-284

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  31 in total

1.  Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients.

Authors:  Hartmut H Malluche; Hanna W Mawad; Marie-Claude Monier-Faugere
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

2.  Stimulation of undermineralized matrix formation by 1,25 dihydroxyvitamin D3 in long bones of rats.

Authors:  J M Hock; M Gunness-Hey; J Poser; H Olson; N H Bell; L G Raisz
Journal:  Calcif Tissue Int       Date:  1986-02       Impact factor: 4.333

Review 3.  Therapeutic applications of vitamin D analogues.

Authors:  J Reeve
Journal:  Br Med J       Date:  1979-10-13

4.  24,25(OH)2D3, bone formation, and bone resorption in vitamin D-deficient, azotemic rats.

Authors:  W G Goodman; D J Baylink; D J Sherrard
Journal:  Calcif Tissue Int       Date:  1984-03       Impact factor: 4.333

5.  Decreased serum 24,25-dihydroxy vitamin D concentrations in children receiving chronic anticonvulsant therapy.

Authors:  Y Weisman; A Fattal; Z Eisenberg; S Harel; Z Spirer; A Harell
Journal:  Br Med J       Date:  1979-09-01

6.  Extraction of vitamin D metabolites by bones of normal adult dogs.

Authors:  K Olgaard; J Schwartz; D Finco; M Arbelaez; J Haddad; L Avioli; S Klahr; E Slatopolsky
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

7.  Histological observations on the failure of rachitic rat bones to respond to 1,25/OH)2D3.

Authors:  J A Gallagher; D E Lawson
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

8.  Vitamin D status after total gastrectomy.

Authors:  K Kozawa; M Imawari; H Shimazu; O Kobori; T Osuga; Y Morioka
Journal:  Dig Dis Sci       Date:  1984-05       Impact factor: 3.199

9.  Vitamin D3 analogs and salmon calcitonin partially reverse the development of renal osteodystrophy in rats.

Authors:  G Jablonski; B M Mortensen; K H Klem; L Mosekilde; C C Danielsen; J O Gordeladze
Journal:  Calcif Tissue Int       Date:  1995-11       Impact factor: 4.333

10.  Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse.

Authors:  P J Marie; R Travers; F H Glorieux
Journal:  Calcif Tissue Int       Date:  1982-03       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.